Advertisement
Canada markets closed
  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     
  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • CAD/USD

    0.7282
    -0.0004 (-0.06%)
     
  • CRUDE OIL

    79.22
    +0.84 (+1.07%)
     
  • Bitcoin CAD

    84,646.17
    -1,811.19 (-2.09%)
     
  • CMC Crypto 200

    1,312.71
    +18.03 (+1.40%)
     
  • GOLD FUTURES

    2,316.40
    -7.80 (-0.34%)
     
  • RUSSELL 2000

    2,055.14
    -9.51 (-0.46%)
     
  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     
  • NASDAQ

    16,302.76
    -29.80 (-0.18%)
     
  • VOLATILITY

    13.00
    -0.23 (-1.74%)
     
  • FTSE

    8,354.05
    +40.38 (+0.49%)
     
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • CAD/EUR

    0.6774
    +0.0003 (+0.04%)
     

Newmont (NEM) Shares Up 13% in 3 Months: What's Driving It?

Shares of Newmont Corporation NEM have gained 12.6% in the past three months. The stock has also outperformed the industry’s growth of 10.3% and the S&P 500’s rise of 9.2% in the said period.



Newmont has a market cap of roughly $34.8 billion. Average volume of shares traded in the past three months was around 6,313.7K. The company has an expected earnings per share growth rate of 46.3% for 2020.

Let’s discuss the factors that are driving the stock.

Driving Factors

Dividend hike, disciplined capital allocation strategy and healthy prospects are some key factors contributing to the company’s share price appreciation.

Earlier this month, the company unveiled plans to hike its quarterly dividend to 25 cents per share or an expected annual dividend of $1 per share. The latest hike, which will be effective upon the approval and declaration of its first-quarter dividend in April 2020, represents 79% increase from 14 cents per share declared in October 2019.

The dividend hike is in line with the company’s disciplined approach to capital allocation strategy and supports its industry leading return profile.

Moreover, the company intends to continue its share repurchase program for up to $1 billion of common stock that was announced in December 2019. The company has used the repurchase program to retire 12.4 million shares worth $506 million for the quarter ended Dec 31, 2019. Overall, the company has returned around $1.4 billion to shareholders in 2019.

Newmont has successfully completed the divestment of its 50% interest in Kalgoorlie Consolidated Gold Mines (KCGM) to Northern Star Resources Limited for cash proceeds of $800 million. Earlier, the company had announced the agreements to sell Red Lake in Canada for $375 million and its stake in Continental Gold for $260 million. The company now has 12 top-tier assets located on four continents, which have the most favorable gold mining jurisdictions.

Also, the company has achieved its divestiture target of between $1 billion and $1.5 billion through these divestments. Newmont is expected to receive more than $1.4 billion in cash proceeds in first-quarter 2020.

Newmont Corporation Price and Consensus

 

Newmont Goldcorp Corporation Price and Consensus
Newmont Goldcorp Corporation Price and Consensus

Newmont Corporation price-consensus-chart | Newmont Corporation Quote

ADVERTISEMENT

 

Zacks Rank & Key Picks

Newmont currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the basic materials space are Daqo New Energy Corp DQ, Pan American Silver Corp PAAS and Commercial Metals Company CMC, each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Daqo New Energy has projected earnings growth rate of 315.4% for 2020. The company’s shares have skyrocketed 130.3% over a year.

Pan American Silver has an estimated earnings growth rate of 46.3% for 2020. Its shares have returned 51.1% in the past year.   

Commercial Metals has an expected earnings growth rate of 17.3% for fiscal 2020. The company’s shares have rallied 43.2% in the past year.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
DAQO New Energy Corp. (DQ) : Free Stock Analysis Report
 
Newmont Goldcorp Corporation (NEM) : Free Stock Analysis Report
 
Pan American Silver Corp. (PAAS) : Free Stock Analysis Report
 
Commercial Metals Company (CMC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research